GlassScriptPhysician profile
Salahuddin Kaddoura
NPI 1538102322
$1,074.52
in general payments reported to CMS, 2019-2025
21 companies · $59.12 in 2025
The $59.12 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $182 · 2020: $212 · 2021: $196 · 2022: $242 · 2023: $67.55 · 2024: $117 · 2025: $59.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $243.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $208.46 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $127.60 | 2019-2024 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $108.86 | 2020-2023 | Rybelsus |
| Amgen INC. | $106.46 | 2019-2024 | Prolia, Evenity |
| Pfizer INC. | $82.66 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.27 | 2020 | |
| Supernus Pharmaceuticals, INC. | $45.00 | 2019-2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $43.28 | 2024-2025 | Caplyta |
| Glaxosmithkline, LLC. | $42.98 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $42.72 | 2019-2020 | |
| Allergan, INC. | $40.81 | 2019-2020 | |
| Exact Sciences Corporation | $33.64 | 2024-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $23.98 | 2022 | |
| Amarin Pharma, INC. | $18.48 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $17.95 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $17.45 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.67 | 2022 | |
| Astellas Pharma US INC | $14.30 | 2022 | |
| Shield Therapeutics INC | $13.43 | 2024 | |
| Sanofi-Aventis U.S. LLC | $11.34 | 2020 | |
| Mylan Specialty L.P. | $11.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salahuddin Kaddoura listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.